Anika to Participate in Upcoming Virtual Investor Conferences
May 04 2021 - 10:30AM
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint
preservation company in early intervention orthopedics, today
announced that Dr. Cheryl Blanchard, President and Chief Executive
Officer and Michael Levitz, Executive Vice President, Chief
Financial Officer and Treasurer, will be participating at the
following three virtual investor conferences in May:
- The 16th Annual Canaccord Genuity Musculoskeletal Conference on
Thursday, May 20, 2021 will host a live presentation starting at
9:00 a.m. ET.
- The UBS Global Healthcare Virtual Conference on Tuesday, May
25, 2021 will host a live presentation starting at 8:00 a.m.
ET.
- Oppenheimer’s MedTech, Tools &
Diagnostics Summit will post a pre-recorded presentation on
Wednesday, May 26, 2021.
Webcasts of all events will be available in the
Investor Relations section of Anika’s
website, www.anika.com. An audio archive of the all the
presentations will also be available on the website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a
global joint preservation company that creates and delivers
meaningful advancements in early intervention orthopedic care. We
partner with clinicians to understand what they need most to treat
their patients and we develop minimally invasive products that
restore active living for people around the world. We are committed
to leading in high opportunity spaces within orthopedics, including
osteoarthritis pain management, regenerative solutions, soft tissue
repair and bone preserving joint technologies. Anika is
headquartered in Massachusetts with operations in the United States
and Europe. For more information about Anika, please visit
www.anika.com.
For Investor Inquiries:Mark
Namaroff Anika Therapeutics, Inc.Executive Director, Investor
Relations and Corporate CommunicationsDirect:
781-457-9287mnamaroff@anika.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2023 to Mar 2024